Pump Changes Aid Fasting Safety
2026-10-03
The insulin pump screen matters more than ritual anxiety. That matters. A first-of-its-kind Israeli study found that most young people with type 1 diabetes completed Jewish fasts safely when insulin delivery was adjusted. The result does not make fasting a casual experiment; it argues that physiology, rather than blanket prohibition, should set the terms.
The signal is encouraging, not permissive. Basal insulin shifts. During a fast, it works less like a fixed pipeline than a background process recalibrating against lower glucose availability; the biology behind that image is insulin pharmacokinetics and hepatic glucose output. Risk still moves. Pump adjustments may reduce hypoglycemia while retaining enough insulin to limit hyperglycemia and ketosis. Continuous glucose monitoring supplies the warning layer.
The real gain is individualized control. Bodies differ. Insulin sensitivity, illness, activity, prior glucose control, and fasting duration can alter the margin for error, which keeps clinical supervision at the center of any decision. Yet the study points toward a more responsive model: pumps, glucose sensors, and dosing rules can operate as a control system rather than as separate tools. The hard question is whether such systems can flag danger before a fasting body feels it.
Loading...
